Pepscan is a biopharmaceutical company, applying its profound understanding of peptides for the discovery of new therapeutic drugs as well as for a range of specialty peptide products and services. Pepscan is a world leader in protein mimicry. Many proteins exert their biological activity through relatively small regions of their folded surfaces.
The challenge is to reproduce these bioactive surfaces by much smaller peptides. Pepscan's unique CLIPS technology platform addresses this issue via the design and synthesis of conformationally constrained peptides with a well-defined 3D spatial structure resembling the native functional protein surface.